Database | Recombinant Antibodies And Mimetics Database

What can we help you find?

You are searching for:

Category A

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category B

Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation

Category C

Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category D

Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation

Category E

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Category F

Original source/host: Animal
Discovery method: immunisation-based selection post 2020
Production: Recombinant expression with animal-derived biomaterials used in production or final formulation

Category G

Original source/host: Unknown
Discovery method: Unknown
Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation

Uncategorised Antibodies

Uncategorised Antibodies have Antibody/Binder Origins set in such a way as to prevent them from being assigned to a valid Antibody Category.

Click here to view all Antibody Category descriptions and to search directly by Antibody Category

Category A
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category B
- Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
- Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
- Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
Search
Category C
- Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
- Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category D
- Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
- Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
- Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
Search
Category E
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search
Category F
- Original source/host: Animal
- Discovery method: immunisation-based selection post 2020
- Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
Search
Category G
- Original source/host: Unknown
- Discovery method: Unknown
- Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
Search

401-410 of 8849 results

Catalogue Number:

RXX00403-100

Category:

Anti-Bacillus anthracis PA/pagA/PA-83 Antibody (SAA1377)

Target:	Protective antigen/ PA/ Anthrax toxins translocating protein/ PA-83/ PA83/ Protective antigen PA-20/ PA-20/ PA20/ Protective antigen PA-63/ PA-63/ PA63/ pagA/ pag/ pXO1-110/ BXA0164/ GBAA_pXO1_0164
Species Reactivity:	Other
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1/ kappa
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RXX00401-100

Category:

Anti-Bacillus anthracis PA/pagA/PA-83 Nanobody (SAA1225)

Target:	PA/pagA/PA-83
Target Alias Name:	anti-Protective antigen/ anti-PA/ anti-Anthrax toxins translocating protein/ anti-PA-83/ anti-PA83/ anti-Protective antigen PA-20/ anti-PA-20/ anti-PA20/ anti-Protective antigen PA-63/ anti-PA-63/ anti-PA63/ anti-pagA/ anti-pag/ anti-pXO1-110/ anti-BXA0164/ anti-GBAA_pXO1_0164
Species Reactivity:	Other
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	VHH-8His-Cys-tag
Host Species:	Other
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RXX52001-100

Category:

Anti-Baker’s yeast GCN4/AAS3 Antibody (SAA0352)

Target:	GCN4/ AAS3/ ARG9/ General control protein GCN4/ Amino acid biosynthesis regulatory protein/ Baker's yeast/ Saccharomyces cerevisiae
Species Reactivity:	Other
Type:	Primary Recombinant
Isotype/Mimetic:	IgG2a/ kappa
Host Species:	Mouse
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RGE07601-100

Category:

Anti-BC2-tag (PDRKAAVSHWQQ) Nanobody (SAA1411)

Target:	CTNNB1
Target Alias Name:	anti-CTNNB/ anti-Catenin beta-1/ anti-CTNNB1/ anti-Beta-catenin
Species Reactivity:	Human
Type:	Primary Recombinant
Isotype/Mimetic:	VHH-His
Host Species:	Other
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

ABCD_AT552

Category:

anti-BDNF antibody

References available

Targets:	BDNF, Brain-derived neurotrophic factor, Abrineurin
Target Alias Name:	UniProt:P23560
Species Reactivity:	Human
Application:	ELISA
Other Applications:	Fluorescence-based assay, Kinetic exclusion assay, Surface plasmon resonance
Type:	Primary Recombinant
Isotype/Mimetic:	ScFv
Host Species:	Human, Mouse, Rabbit, Rat, Other
Formulation:	Non-purified HEK293 cell supernatant (+0.02% sodium azide), Sodium-azide free on demand
Animal-Derived Biomaterials Used:	None
Sequence Available	Yes
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	Yes
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RZZ02001-100

Category:

Anti-Bet v 1/Allergen Bet v I-A Antibody (SAA0655)

Target:	BETVIA/ BETVI/ Major pollen allergen Bet v 1-A/ Allergen Bet v 1-A
Species Reactivity:	Other
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RZZ02002-100

Category:

Anti-Bet v 1/Allergen Bet v I-A Antibody (SAA0656)

Target:	BETVIA/ BETVI/ Major pollen allergen Bet v 1-A/ Allergen Bet v 1-A
Species Reactivity:	Other
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RZZ02003-100

Category:

Anti-Bet v 1/Allergen Bet v I-A Antibody (SAA0657)

Target:	BETVIA/ BETVI/ Major pollen allergen Bet v 1-A/ Allergen Bet v 1-A
Species Reactivity:	Other
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RZZ02004-100

Category:

Anti-Bet v 1/Allergen Bet v I-A Antibody (SAA0658)

Target:	BETVIA/ BETVI/ Major pollen allergen Bet v 1-A/ Allergen Bet v 1-A
Species Reactivity:	Other
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Catalogue Number:

RZZ02005-100

Category:

Anti-Bet v 1/Allergen Bet v I-A Antibody (SAA0659)

Target:	BETVIA/ BETVI/ Major pollen allergen Bet v 1-A/ Allergen Bet v 1-A
Species Reactivity:	Other
Application:	ELISA
Type:	Primary Recombinant
Isotype/Mimetic:	IgG1
Host Species:	Human
Animal-Derived Biomaterials Used:	None
Sequence Available	No
Original Discovery Method	Unknown
Original Discovery Information Provided On Datasheet	No
Antibody/Binder Origins:	Unknown discovery source/method, In vitro recombinant expression

Viewing 401-410 of 8849 results

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.